Mpox is a viral infection that can cause fever, swollen glands, and a painful or itchy rash. Many people first notice the early symptoms of mpox after close skin-to-skin contact, and some also feel tired, achy, or unwell. Mpox can affect children and adults, but most people recover within 2 to 4 weeks. Not everyone will have the same experience. Treatment is usually supportive, such as pain relief, fluids, and skin care, but antiviral medicine may be used for severe mpox or for people at higher risk of complications, and deaths are uncommon in settings with good medical care.
How many people live with Mpox?
Because mpox is usually a short-term infection, health agencies track reported cases rather than how many people are living with it at one moment. Since the 2022 outbreak, more than 100,000 mpox cases have been reported worldwide (World Health Organization, 2025), including about 33,000 cases in the United States (Centers for Disease Control and Prevention, 2025).
Overview
MpoxSymptoms
Mpox often starts with fever, chills, headache, muscle aches, swollen lymph nodes, and tiredness. A few days later, a painful or itchy rash can appear, often on the face, genitals, hands, or feet. Early symptoms of Mpox can feel flu-like.
Outlook and prognosis
For most people with mpox, the outlook is good, and symptoms clear within 2 to 4 weeks. Some living with mpox, especially those with weakened immune systems, can have more severe illness and may need closer medical care.
Causes and risk factors
Mpox is caused by the monkeypox virus. Risk is higher after close skin-to-skin contact, exposure to body fluids, shared bedding or towels, and contact with infected animals. Crowded living conditions, multiple sexual partners, and limited access to vaccination can raise risk.
Genetic influences
Genetics usually matter less than exposure and immune status in Mpox. Small differences in immune-related genes may affect susceptibility or illness severity, but no single inherited change is known to strongly determine who gets Mpox.
Diagnosis
Mpox is diagnosed by a clinician based on the rash and other symptoms, then confirmed with a lab test, usually a PCR swab from a skin lesion. Blood tests are not the main test for early symptoms of Mpox.
Treatment and drugs
Mpox treatment focuses on easing pain, fever, itching, and skin sores while the body clears the infection. Some people with severe mpox, eye involvement, or weak immune systems may need antiviral medicine and close medical care.
Symptoms
Mpox often starts with feeling unwell and then a rash, but the pattern is not the same for everyone. You might notice small changes at first, such as fatigue, fever, swollen glands, or a sore throat before skin lesions appear. The early symptoms of mpox can look like a flu-like illness, while some people have only a few sores and little or no fever. In many cases, symptoms come on over several days and then gradually improve as the sores heal.
Many people with mpox develop a fever, chills, or both near the start of the illness. This can feel a lot like coming down with the flu, with a sudden sense of being sick or run-down.
Tender, swollen lymph nodes are common in mpox, often in the neck, armpits, or groin. This can make the body feel sore and achy, and it may be one clue that helps separate mpox from some other rashes.
The rash may begin as small spots and then turn into raised bumps, blisters, or pus-filled sores before scabbing over. Some people with mpox have many lesions, while others may have only one or a few.
Mpox sores can be painful, itchy, or both, especially when they are on the genitals, around the anus, or on sensitive skin. For many, this can mean discomfort with walking, sitting, urinating, or sexual activity.
How people usually first notice Mpox?
Many people first notice mpox when they suddenly feel unwell, often with fever, chills, swollen lymph nodes, headache, muscle aches, or unusual tiredness, and then a rash appears soon after or, in some cases, starts first. The first signs of mpox often include small spots or bumps that can show up on the face, hands, feet, genitals, or around the anus, then change into fluid-filled sores that may be painful or itchy. Because early symptoms can look like the flu or other skin conditions, mpox is often first noticed when that rash keeps evolving in a way that feels clearly out of the ordinary.
Types of Mpox
Different types of Mpox are usually described by the virus group behind the infection, often called a clade. Symptoms don’t always look the same for everyone. In day-to-day life, many people across these types develop a rash, fever, swollen lymph nodes, and feel run down, but the severity and pattern can differ. The main recognized variants of Mpox are Clade I and Clade II, with Clade II split into IIa and IIb.
Clade I
Clade I Mpox has generally been linked with more severe illness than the other main types of Mpox. People may have a widespread rash, fever, swollen lymph nodes, and a higher risk of serious complications, especially in children, pregnant people, or those with weakened immune systems.
Clade IIa
Clade IIa Mpox is usually associated with milder illness than Clade I, although symptoms can still be significant. Many living with this form develop the usual rash and flu-like symptoms, but severe outcomes have tended to be less common overall.
Clade IIb
Clade IIb Mpox is the form linked to the 2022 global outbreak, and it has often shown a somewhat different symptom pattern. Some may find the rash is limited to the genital, anal, or mouth area, with pain, rectal symptoms, or only a few skin lesions instead of a widespread rash. Even within the same type, intensity can range from mild to severe.
Can I slow down the onset of symptoms?
No, there is no good evidence that diet, exercise, sleep, or other lifestyle changes can meaningfully slow the start of mpox symptoms once you have been exposed or infected. What can help is lowering the chance of getting sick in the first place by avoiding close skin-to-skin or sexual contact with someone who has symptoms, not sharing bedding, towels, or clothing, and washing your hands; after a known exposure, a mpox vaccine given soon after may help prevent illness or make it milder, but it does not guarantee this. If you think you were exposed, getting medical advice early is the best next step, and acting quickly may help even though it cannot promise you will stay well.
What genetics can tell you about symptoms
For mpox, genetics can help explain why illness is not always the same from one person to another, but it usually cannot predict exactly which symptoms someone will get. Differences in the virus itself can affect how easily it spreads and may influence the typical pattern or severity of symptoms across outbreaks, while a person’s own immune-related genes may also play a small part in how strongly their body reacts. Even so, everyday factors such as close exposure, immune health, age, skin condition, and access to care usually matter more than genetics in deciding when symptoms start and how severe they become.
Causes and risk factors
Mpox is caused by infection with the mpox virus, most often after close skin-to-skin or sexual contact with someone who has it. The virus can also spread through shared bedding, towels, or clothing, through long face-to-face contact, and in some regions through infected animals. Some of the main risk factors for mpox are having many close contacts and not being vaccinated when it is recommended. There is no known inherited gene that causes mpox, but a weakened immune system, pregnancy, eczema, and young age can raise the risk of severe illness if infection happens. Not everyone with the same risk develops the condition.
What are the most common causes or risk factors?
Mpox is caused by the mpox virus. The biggest risk is close contact with someone who has it, especially touching the rash or scabs, having sexual or other skin-to-skin contact, sharing bedding, towels, or clothing, or spending a long time face-to-face with them. Risk also goes up with contact with infected animals in parts of Central or West Africa, and with travel to or living in places where mpox is spreading.
Environmental and biological risk factors
Mpox risk usually rises through direct exposure rather than casual contact in the same space. The main risk factors for mpox are close contact with an infected person, contact with contaminated objects or animals, and situations where the virus can reach broken skin or moist body surfaces. Doctors often group risks into internal (biological) and external (environmental).
Touching mpox rash, scabs, or body fluids during close personal contact is one of the clearest risk factors. This can happen during caregiving, cuddling, or other prolonged skin-to-skin contact.
Clothing, bedding, towels, or other objects used by someone with mpox can carry the virus for a time. Risk is higher when these materials touch skin or are handled before proper cleaning.
Long periods of close face-to-face contact can expose someone to respiratory secretions from an infected person. This matters more in enclosed spaces and during caregiving than in brief casual encounters.
Living with someone who has mpox raises the chance of repeated exposure through touch, shared rooms, and contaminated surfaces. Risk often builds over several days because contact may happen more than once.
Genetic risk factors
Many people wondering about genetic risk factors for mpox should know that mpox is not usually an inherited condition. There is no known single gene change that causes most people to get mpox, and family history alone does not make it run in families the way inherited disorders do. Some risk factors are inherited through our genes. In rare cases, inherited immune system disorders may make it harder to fight the virus and can raise the chance of more severe illness.
Not inherited: Mpox is an infection, not a condition passed directly from parent to child through genes. If several relatives have had mpox, that usually does not mean the disease itself is hereditary.
No common gene: Researchers have not found a common inherited gene change that clearly explains who gets mpox. For most people, there are no established genetic causes of mpox.
Rare immune disorders: A small number of people are born with inherited immune problems that weaken antiviral defenses. In those rare cases, mpox may be harder for the body to control, and severe illness can be more likely. Evidence in mpox is still limited, so this is not considered a typical risk factor for most people.
Lifestyle risk factors
Mpox is mainly spread through close personal contact, so the main lifestyle risk factors relate to situations that increase skin-to-skin, sexual, or household exposure. For mpox, lifestyle risk factors are less about causing the disease and more about increasing the chance of infection or passing it to others. Understanding how lifestyle affects mpox can help lower exposure during outbreaks and reduce complications during recovery.
Prolonged skin-to-skin contact with someone who has mpox lesions, rashes, or body fluids raises the chance of transmission. This includes intimate contact, cuddling, massage, or other direct physical contact.
Having sex with new or multiple partners can increase exposure when mpox is circulating in a sexual network. Contact with lesions in the genital, anal, or oral area can spread infection even before someone realizes what the rash is.
Sharing bedding, towels, clothing, fetish gear, or personal items can pass virus from contaminated materials to another person. Washing fabrics and avoiding shared use during illness helps reduce this risk.
Attending parties, clubs, festivals, or other crowded events with close physical contact can raise the chance of exposure. Risk is higher when contact is prolonged and involves direct skin contact or shared spaces for changing and resting.
Risk prevention
Mpox spreads mainly through close skin-to-skin contact, contact with body fluids or contaminated items, and sometimes through prolonged face-to-face contact. Many living with mpox exposure concerns want clear, practical ways to lower risk in daily life, especially during outbreaks or if a partner is sick. Prevention is about lowering risk, not eliminating it completely. Vaccination, avoiding direct contact with rash or sores, and acting quickly if symptoms start are the main ways to reduce the chance of getting mpox or passing it to others.
The mpox vaccine can lower the risk of infection and may also make illness milder if given soon after a known exposure. It is most often recommended for people with higher exposure risk, such as close contacts of a confirmed case or some people with multiple sexual partners in an outbreak setting.
The best way to prevent mpox is to avoid direct skin-to-skin contact with a rash, scabs, or body fluids from someone who may be infected. This matters during sex, kissing, cuddling, and other close contact where skin and mucous membranes touch.
Condoms may not fully prevent mpox because sores can be on skin not covered by a condom, but they can still lower exposure to body fluids and some related infections. During outbreaks, reducing the number of sexual partners and avoiding sex with anyone who has a new rash, fever, or swollen glands can help lower risk.
Clothes, bedding, towels, sex toys, and other personal items can carry the virus if they have touched sores or body fluids. Not sharing these items, and washing them well after use, helps reduce the spread of mpox.
Can you prevent Mpox?
You cannot prevent mpox with complete certainty, but you can lower the chance of getting it. The best-known ways are to avoid close skin-to-skin contact, including sexual contact, with someone who has a new rash or sores, avoid sharing bedding, towels, or clothing, wash your hands after close contact, and clean shared surfaces. Vaccination can also help prevent mpox or make it milder for some people, especially after a known exposure or for those at higher risk.
Transmission
Mpox spreads mainly through close contact with the rash, scabs, or body fluids of someone who has it, and it can also pass during prolonged face-to-face contact through respiratory secretions or by sharing items like bedding, towels, or clothing that touched the sores. In pregnancy, Mpox can also pass to the baby.
To understand how Mpox spreads, it helps to know that it is usually less contagious than infections that move easily through the air, such as measles, because most people catch Mpox through direct, close contact rather than from briefly being in the same room. People with Mpox can spread it from the time symptoms start until all sores have healed, the scabs have fallen off, and fresh skin has formed.
When to test your genes
For mpox, genetic testing of your own DNA is not used for early detection or to tailor routine care. If you have a new rash, close exposure, or symptoms after travel or contact, the right test is a viral swab or PCR for mpox, not a hereditary gene test.
Diagnosis
Mpox is usually diagnosed when a rash or sores, fever, swollen lymph nodes, or body aches lead someone to seek care. The diagnosis of mpox often starts with the pattern of symptoms and a close look at the skin, especially if the rash changes over several days from spots to fluid-filled bumps and then crusts. It’s natural to worry when symptoms don’t have a clear explanation, but testing can usually confirm whether mpox is the cause.
Doctors ask about recent symptoms, close contact with someone who may have mpox, travel, and sexual or household exposures. This helps them judge how likely mpox is and when testing should be done.
A clinician looks at the number, location, and stage of the rash or sores, including areas such as the face, hands, genitals, or around the anus. Swollen lymph nodes can be an important clue because they are more common in mpox than in some other rash illnesses.
The main test is a swab taken from one or more skin lesions and checked with a lab test called PCR, which looks for mpox virus genetic material. This is the most reliable way to confirm how mpox is diagnosed in someone with an active rash.
Doctors also consider other causes of a similar rash, such as chickenpox, herpes, syphilis, allergic skin reactions, or bacterial skin infections. Blood tests or swabs for these conditions may help rule out common alternatives when the diagnosis is unclear.
How is Mpox diagnosed?
Doctors usually suspect mpox from the pattern of symptoms, especially a new rash or sores, swollen glands, fever, and whether someone has had close contact with a person who may have the infection. To confirm it, they usually take a swab from the skin sores or scabs and send it to a lab to check for the virus; this is the main test used in practice. Blood tests are not usually the best way to diagnose mpox, especially early on.
Stages of Mpox
Mpox often follows a fairly clear course, although the timing and symptoms can vary from one person to another. Some people have only a few skin lesions and mild illness, while others feel unwell for days before the rash appears. Often the process begins when you notice changes in daily life, such as fever, swollen glands, or painful spots on the skin.
Incubation period
This is the time after exposure when mpox is in the body but no symptoms are noticed yet. It usually lasts several days to a few weeks. People generally do not feel sick during this stage.
Early illness
The early symptoms of mpox can include fever, chills, headache, muscle aches, tiredness, and swollen lymph nodes. Some people feel as if they are coming down with the flu. Others may have very mild symptoms or skip this stage almost entirely.
Rash stage
A rash or sores then appear, often on the genitals, anus, mouth, face, hands, or other parts of the body. The spots change over time, usually starting flat, then becoming raised, fluid-filled, and later crusted. For many, this is the most uncomfortable stage because lesions can be painful or itchy.
Healing stage
The sores dry up, scab over, and new skin forms underneath. As healing continues, pain and swelling usually ease. People with mpox are generally considered contagious until all lesions have healed and fresh skin has formed.
Outlook and prognosis
Most people with mpox recover fully within 2 to 4 weeks with supportive care, and the outlook is generally good, especially in otherwise healthy individuals with access to medical care. However, disease can be more severe in infants, pregnant people, people with weakened immune systems, and those with extensive skin disease or complications such as secondary bacterial infection, pneumonia, encephalitis, or eye involvement that can threaten vision. In recent outbreaks caused mainly by clade II virus, the case-fatality rate has been low, often well under 1% in settings with good healthcare, but mortality can be higher where access to treatment is limited or in outbreaks involving more virulent clades. Clade I mpox has historically been associated with substantially higher death rates than clade II, although exact risk varies by outbreak, age, nutrition, and underlying health. Early diagnosis, pain control, hydration, treatment of complications, and antiviral therapy when indicated can improve outcomes. Some people may have lasting scars, pigment changes, or rarely chronic pain or visual problems after recovery.
Long-term effects
Most people with Mpox get better fully, but recovery can take time and some effects may linger after the rash and fever are gone. The long-term effects of Mpox are usually related to skin healing, pain, scarring, or problems linked to where the sores were located, such as the eyes or genitals. People who had severe illness, many lesions, or a weakened immune system are more likely to have ongoing problems. It is important to remember that long-term does not always mean progressive.
Mpox sores can leave darker or lighter marks and sometimes permanent scars after they heal. This can be more noticeable if lesions were deep, became infected, or were scratched during recovery.
Some people have pain or burning in areas where lesions were severe, especially around the genitals or anus. For many, this improves over weeks, but a few may have longer-lasting nerve-related discomfort.
If Mpox affects the eye, it can lead to lingering redness, light sensitivity, blurred vision, or scarring on the front of the eye. In more serious cases, this can cause lasting vision loss.
Lesions on the penis, vulva, or nearby tissues can leave tenderness, scarring, or discomfort with urination or sex for a time after the infection clears. Swelling and secondary infection can make healing slower.
How is it to live with Mpox?
Living with mpox can be physically draining and socially stressful at the same time. The rash or sores can be painful or itchy, fever and swollen lymph nodes can leave people feeling wiped out, and everyday tasks like walking, sleeping, working, or caring for children may become harder until the illness clears. Because mpox can spread through close physical contact, many people need to isolate for a period of time and avoid intimate contact, which can affect family routines, relationships, and caregiving, but with rest, symptom care, and sensible precautions, most people recover fully.
Treatment and drugs
Mpox treatment is mostly about easing symptoms and helping the body recover, since many people get better with rest, fluids, pain relief, and good skin care for the rash. If sores are painful or in sensitive areas such as the eyes, mouth, genitals, or rectum, treatment may also include wound care, medicines for pain or itching, and help preventing dehydration or bacterial skin infection. For people at higher risk of severe illness, such as those with a weakened immune system, severe skin disease, or certain complications, doctors may consider an antiviral medicine called tecovirimat, although access and use can vary by country and situation. Not every treatment works the same way for every person, and people living with Mpox may need closer monitoring in the hospital if they have trouble breathing, severe pain, confusion, or cannot drink enough fluids.
Can you cure Mpox?
There is no specific cure that makes mpox go away right away, but most people get better on their own with time and supportive care. Treatment focuses on easing pain, fever, itching, and skin sores, and some people with severe illness or a higher risk of complications may be offered antiviral medicine. For many living with mpox, this means rest, fluids, and close medical follow-up while the body clears the infection.
Non-drug treatment
Mpox can make everyday life uncomfortable, especially when skin sores, mouth pain, or rectal pain make it hard to eat, sleep, or use the bathroom. Managing this condition often means supportive care at home or in clinic to protect the skin, ease pain, prevent dehydration, and lower the chance of spreading the virus to others. Many people with mpox improve with rest, fluids, careful hygiene, and close follow-up, while those with severe pain, eye symptoms, or trouble breathing need urgent medical care.
Staying away from close physical contact helps reduce spread while sores are active. This usually means avoiding sex, kissing, shared bedding, and skin-to-skin contact until all lesions have healed and fresh skin has formed.
Gentle washing with soap and water and keeping lesions clean and dry can help protect the skin. For many, home care for mpox rash includes loose clothing, clean bandages when needed, and avoiding picking or shaving over sores.
Sitz baths or warm soaks can ease pain around the genitals or anus and make bowel movements less distressing. Patting the area dry rather than rubbing can help reduce irritation.
Drinking enough water and eating soft, simple foods can help if mouth sores make swallowing painful. Rest also supports recovery, especially when fever and body aches leave you drained.
Your genes may have an impact on how drugs work for you
For mpox, treatment usually focuses on easing symptoms like pain, fever, and itching, and in some cases an antiviral medicine may be used for severe illness. In general, small inherited differences can affect how fast the body breaks down some medicines or how likely side effects are, so one person may get more benefit or more problems than another from the same dose. But for mpox, gene-based drug testing is not a routine part of care right now, because there is not yet a well-established need for it in most people living with this infection.
Pharmacological treatments
Most people with Mpox get better with supportive care, but medication may be used when symptoms are severe, pain is hard to control, or the risk of complications is higher. The main antiviral used for Mpox is tecovirimat, while brincidofovir and cidofovir are less commonly considered in selected situations. Some people also need medicines for pain, itching, fever, or bacterial skin infections that can happen on top of Mpox sores. Not everyone responds to the same medication in the same way.
Tecovirimat is the antiviral most often used for Mpox when treatment is needed, especially for severe illness or in people at higher risk of complications. It works by blocking the virus from spreading easily in the body. Doctors may consider it if Mpox affects the eyes, genitals, or causes serious pain, or if early symptoms of Mpox are quickly getting worse.
Brincidofovir is another antiviral that may be considered in special cases, but it is used far less often than tecovirimat. It can affect the liver, so blood tests and close follow-up may be needed. Its role in Mpox is still limited compared with first-choice treatment.
Cidofovir is an older antiviral that may be used only in severe or complicated Mpox when other options are not suitable. It can strain the kidneys, so it is usually given with careful monitoring and extra fluids. Because of these risks, it is not a routine treatment for most people with Mpox.
Vaccinia immune globulin intravenous, called VIGIV, is a purified antibody treatment that may be considered for some people with severe Mpox, especially if the immune system is very weak. It is not standard for most cases and is usually reserved for specialist care. In some cases, medicines are combined for severe disease, but this depends on the person and the treatment setting.
Genetic influences
Mpox is not considered an inherited condition, so most people do not get it because it runs in the family. It’s natural to ask whether family history plays a role. In mpox, genetics matter more in two other ways: the genetic makeup of the virus itself, and small gene differences that can shape how strongly someone’s immune system responds. Different versions of the mpox virus can affect how easily it spreads and how severe the illness may be. On the human side, researchers think some inherited differences in immune defenses may help explain why one person has a mild case while another becomes much sicker, but this is still an area of active study and is not something doctors routinely test for. If you are wondering whether mpox is hereditary, the short answer is no; exposure is the main driver, although rare inherited immune system problems can raise the risk of severe infection.
Is Mpox genetic?
Genetics usually matter less than exposure and immune status in Mpox. Small differences in immune-related genes may affect susceptibility or illness severity, but no single inherited change is known to strongly determine who gets Mpox.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal and common part of human biology. Most do not directly affect health and simply reflect the natural differences seen among people. For many genes, carrying a variant connected to a condition points to a possible link, not a definite diagnosis, especially when several genes and environmental factors are part of the picture. In some cases, though, a single well-studied variant in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For most people with mpox, treatment choices are guided more by symptoms, risk of complications, and immune status than by genetic testing. Someone with a mild rash may mainly need pain relief, fluids, and skin care, while people with severe pain, eye involvement, or a weakened immune system may be offered an antiviral such as tecovirimat. Not every difference in response is genetic, but genes can affect how the body processes medicines in general. For mpox, however, there is no widely used pharmacogenetic test that reliably tells doctors which drug will work best or what dose to use, so treatment is not usually tailored around a person’s genes. If you are looking into how genetics affect mpox treatment, the practical answer is that genetics plays only a small role in routine care today. Researchers also watch changes in the mpox virus itself, because viral mutations can sometimes affect how well antivirals work, but this is mainly a research and public health issue rather than something most people will notice during care.
Interactions with other conditions
Mpox can be harder on the body when it happens alongside other illnesses, especially conditions that weaken the immune system, such as untreated HIV, some cancers, or medicines taken after an organ transplant. In these situations, the rash may be more widespread, symptoms can last longer, and the risk of complications like severe skin infection, pneumonia, or eye involvement may be higher. Doctors call it a “comorbidity” when two conditions occur together. For many living with eczema or other skin conditions, broken or inflamed skin may make mpox lesions more painful and can raise the chance of secondary bacterial infection. Another practical concern is sexual health: mpox can occur at the same time as sexually transmitted infections, so testing for both may be important when early symptoms of mpox include genital or anal sores. Talk with your doctor about how your conditions may influence each other, especially if you are pregnant, have a weakened immune system, or are being treated for another serious illness.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Mpox?
Mpox can look like other illnesses that cause a rash or sores, especially chickenpox, shingles, herpes, syphilis, and hand-foot-and-mouth disease. In some people, it can also be mistaken for a bad allergic skin reaction or another virus that causes fever, body aches, and swollen glands. Because these problems can overlap so much, a medical test is often needed to tell them apart.
History
A rash like this can be unsettling, especially when it comes with fever, swollen glands, or painful sores that make eating, sleeping, or using the bathroom harder. For many people, that day-to-day impact is what brings mpox into focus, even though the condition has been recognized by medicine for decades.
Mpox was first identified in laboratory monkeys in 1958, which is how the name first entered medical use, but the infection is mainly linked to small mammals rather than monkeys. The first known human case was recorded in 1970 in Central Africa, during a period when health workers were closely tracking illnesses that looked like smallpox. Early on, mpox was understood mostly through the pattern of fever, rash, and swollen lymph nodes, and many cases were reported in parts of West and Central Africa where the virus had been present for a long time.
As medical science evolved, doctors and public health teams learned that mpox could spread through close contact with infected animals, skin lesions, body fluids, and contaminated materials, and also through close person-to-person contact. Over time, descriptions became clearer, including the fact that symptoms can vary. Some people develop a more widespread rash, while others have fewer sores, mainly in the genital or anal area, which can make the early symptoms of mpox easier to mistake for another infection.
For many years, mpox was discussed mostly in relation to outbreaks in African countries, and it often received too little global attention. That changed in 2022, when cases were reported across Europe, the United States, and many other regions, often spreading through close physical contact within social and sexual networks. This outbreak led to much broader public awareness, faster testing, updated advice on prevention, and wider discussion about stigma and the need for respectful care.
The name itself also changed in recent years. Because older naming raised concerns about stigma and inaccuracy, health authorities moved toward using mpox instead of the older term. Today, the history of mpox is still being written, but it is much better understood than it once was. Researchers have clarified that it is a viral infection with recognized patterns of spread, and that prompt diagnosis, supportive care, and public health measures can make a real difference for people living with mpox and their communities.